PCR / NGS
QUASAR-BRCA1/2
The testing kit is designed to detect germline and somatic mutations in the BRCA1, BRCA2 genes by NGS-sequencing and is recommended for determining predisposition to developing hereditary forms of breast cancer, ovarian cancer in healthy women, and when examining patients diagnosed with breast cancer and ovarian cancer in order to determination of effective treatment tactics.
PCR
HRR-SCREENING
The kit is designed to detect 16 germline mutations in the HRR genes and is used in screening for predisposition to breast, ovarian, prostate, pancreatic, and stomach cancer.
PCR
COV-INFLU-TEST
The kit is designed for diagnostics of the respiratory viral infection caused by the SARS-CoV-2 coronavirus and influenza A and B viruses.
PCR
HEPA-BCD-TEST
The kit is designed for detection and differentiation of the hepatitis B, C and D viruses in patients with suspected infection.
PCR
MTB-RESIST-I-TEST
The kit is designed for detection of mutations associated with drug resistance in the tuberculosis complex mycobacteria DNA with determination of sensitivity to the first-line chemotherapy drugs and their analogues. The result of the assay allows for choosing of an appropriate therapy for patients with the confirmed diagnosis of pulmonary and extrapulmonary tuberculosis.
PCR
ТЕSТ-RHD PLUS
The reagent kit is designed for non-invasive detection of the fetal Rh factor (RHD) gene in the blood plasma of an Rh-negative mother to predict the risk of developing Rh conflict and HDFN.
Designed by